OptimizeRX Corp (NASDAQ: OPRX) has reported a loss for its first fiscal quarter (ending March 31) of $-0.38 versus a loss $-0.37 for the same period a year ago. For the latest four quarters through March 31, E.P.S. were $-1.02 compared to $-0.80 a year ago.
Recent Price Action
OptimizeRX Corp (NASDAQ: OPRX) stock closed at $10.48 on 5/14/24 after a slight decline of -0.6%. However, this decline was accompanied by below average trading volume at 68% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -1.3% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, OPRX is expected to be a modest Value Builder.
OptimizeRX has a current Value Trend Rating of B (Positive). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. OptimizeRX has a slightly negative Appreciation Score of 32 but a very high Power Rating of 94, with the Positive Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment